Yahoo Web Search

Search results

1. • 

     Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock...

     Simply Wall St. via Yahoo Finance· 20 hours ago

     (NASDAQ:REGN), then you'll have to look at the makeup of its share registry. With 85% stake,...

2. • Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Merit Financial Group LLC

     ETF DAILY NEWS· 2 days ago

     Merit Financial Group LLC lessened its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 53.7% in ...

3. • Court Cancels Injunction Hearings In Aflibercept BPCIA Litigation; Regeneron May Seek Temporary...

     JD Supra· 24 hours ago

     Pursuant to that order, Regeneron’s case against Amgen, Inc. (“Amgen”) was transferred from the Central District of California to...

4. • Why Investors Are Eyeing Regeneron Pharmaceuticals Inc (REGN): T

     Guru Focus· 5 days ago

     Regeneron Pharmaceuticals Inc (REGN) has recently captured the attention of investors and financial analysts alike, thanks to its solid financial standing and p

5. • TFF Pharmaceuticals (NASDAQ:TFFP) vs. Alnylam Pharmaceuticals (NASDAQ:ALNY) Financial Contrast

     ETF DAILY NEWS· 1 day ago

     Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) and TFF Pharmaceuticals (NASDAQ:TFFP – Get Free Report) are both medical companies, but which is ...

6. • The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences - April 2024 | JD...

     JD Supra· 4 days ago

     This week, the FTC continued its intense regulatory focus on pharmaceutical patents listed in the FDA’s Orange Book. As reported in earlier editions of The Interplay, the ...

7. • 

     Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

     Zacks via Yahoo Finance· 21 hours ago

     When you look at individual holdings, Neurocrine Biosciences Inc (NBIX) accounts for about 5.26% of...

8. • 

     Intellia's (NTLA) Q1 Earnings & Revenues Beat Estimates

     Zacks via Yahoo Finance· 15 hours ago

     Intellia's (NTLA) earnings and revenues surpass estimates in the first quarter of 2024. The company...

9. • 

     Goldman’s top 50 Strong Balance Sheet stocks (NYSEARCA:SPY)

     Seeking Alpha· 5 days ago

     Goldman Sachs analysts listed 50 stocks constituents of their “strong balance sheet” basket.

10. • Sell in May No Way

      MoneyShow via Yahoo Finance· 4 days ago

      Many investors and members of the financial media have been asking if it will be prudent to heed the old Wall Street adage to “sell in May and go away,” reports chief investment strategist Sam ...